Cancer Research UK logo.
SearchDonate
  • Search

A study to find more about acute lymphoblastic leukaemia (UKALL14 sub study)

Overview

Cancer types:

Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Blood cancers, Leukaemia

Status:

Closed

Phase:

Other

Details

This study is open to people who are newly diagnosed with B cell or T cell acute lymphoblastic leukaemia (ALL) and haven’t started treatment. It is a sub study of the original UKALL14 trial.

In particular, it is for

  • adults between 25 and 65 years old with B cell or T cell acute lymphoblastic leukaemia

  • and for people between 19 and 65 who have ALL with the Philadelphia chromosome.

Cancer Research UK supports this study.

Recruitment start: 1 December 2017

Recruitment end: 29 October 2022

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Adele Fielding

Supported by

Cancer Research UK

NIHR Clinical Research Network: Cancer

Novartis

Roche

CRUK & UCL Cancer Trials Centre

Chugai Pharma UK Ltd

Biovitrum

Sigma Tau

Baxalta

Last reviewed: 02 Dec 2025

CRUK internal database number: 15400

Help and support